Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ETC-1002 in Hypercholesterolemia and Hypertension
NCT02178098Phase 2Completed
- Sponsor
- Esperion Therapeutics
- Start
- Jun 2014
- Primary completion
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bempedoic acid in hypercholesterolemia, sponsored by Esperion Therapeutics. Started Jun 2014; status: completed.
02
Drugs
bempedoic acid
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT02178098.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02178098.